This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: The University of Hong Kong, Versitech, Inc.. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Innovations of Pik To Cheung in Cell-Matrix Technology
Introduction
Pik To Cheung is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cell-matrix technology, holding 2 patents that showcase his innovative approaches to enhancing cell viability and therapeutic applications.
Latest Patents
Cheung's latest patents focus on the development of stable cell-matrix microspheres. These microspheres achieve up to 100% encapsulation efficiency and high cell viability. The methods he has developed utilize matrix or biomaterial systems that typically exhibit poor shape and mechanical stability. His innovations have applications in cell therapeutics, including microinjection and surgical implantation. Additionally, they facilitate 3D culture for in vitro expansion without the need for repeated cell splitting through enzymatic digestion or mechanical dissociation. This technology also enhances the production of therapeutic biomolecules and supports in vitro modeling for morphogenesis studies. The modified droplet generation method he introduced is both simple and scalable, allowing for the production of cell-matrix microspheres even when the matrix or biomaterial system has low concentration and slow phase transition.
Career Highlights
Throughout his career, Cheung has worked with reputable organizations such as Versitech, Inc. and The University of Hong Kong. His experience in these institutions has contributed to his expertise in the field of cell-matrix technology.
Collaborations
Some of his notable coworkers include Hoi Ling Wong and Barbara Pui Chan, who have collaborated with him on various projects.
Conclusion
Pik To Cheung's innovative work in cell-matrix technology has the potential to significantly impact therapeutic applications and research methodologies. His contributions continue to advance the field and inspire future innovations.
